Effectiveness of antipsychotic drugs in patients with chronic schizophrenia JA Lieberman, TS Stroup, JP McEvoy, MS Swartz, RA Rosenheck, ... New England journal of medicine 353 (12), 1209-1223, 2005 | 7428 | 2005 |
Biological insights from 108 schizophrenia-associated genetic loci C Pantelis, GN Papadimitriou, S Papiol, E Parkhomenko, MT Pato, ... Nature 511 (7510), 421-427, 2014 | 7404 | 2014 |
Genome-wide association study identifies five new schizophrenia loci Nature genetics 43 (10), 969-976, 2011 | 1998 | 2011 |
Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia … JP McEvoy, JM Meyer, DC Goff, HA Nasrallah, SM Davis, L Sullivan, ... Schizophrenia research 80 (1), 19-32, 2005 | 1621 | 2005 |
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease LS Schneider, PN Tariot, KS Dagerman, SM Davis, JK Hsiao, MS Ismail, ... New England Journal of Medicine 355 (15), 1525-1538, 2006 | 1457 | 2006 |
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial RSE Keefe, RM Bilder, SM Davis, PD Harvey, BW Palmer, JM Gold, ... Archives of general psychiatry 64 (6), 633-647, 2007 | 1412 | 2007 |
Modeling linkage disequilibrium increases accuracy of polygenic risk scores BJ Vilhjálmsson, J Yang, HK Finucane, A Gusev, S Lindström, S Ripke, ... The american journal of human genetics 97 (4), 576-592, 2015 | 1315 | 2015 |
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment JP McEvoy, JA Lieberman, TS Stroup, SM Davis, HY Meltzer, ... American Journal of Psychiatry 163 (4), 600-610, 2006 | 1232 | 2006 |
Mapping genomic loci implicates genes and synaptic biology in schizophrenia V Trubetskoy, AF Pardiñas, T Qi, G Panagiotaropoulou, S Awasthi, ... Nature 604 (7906), 502-508, 2022 | 1172 | 2022 |
Premature mortality among adults with schizophrenia in the United States M Olfson, T Gerhard, C Huang, S Crystal, TS Stroup JAMA psychiatry 72 (12), 1172-1181, 2015 | 1081 | 2015 |
A national study of violent behavior in persons with schizophrenia JW Swanson, MS Swartz, RA Van Dorn, EB Elbogen, HR Wagner, ... Archives of general psychiatry 63 (5), 490-499, 2006 | 1000 | 2006 |
Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects CR Marshall, DP Howrigan, D Merico, B Thiruvahindrapuram, W Wu, ... Nature genetics 49 (1), 27-35, 2017 | 916 | 2017 |
Microduplications of 16p11. 2 are associated with schizophrenia SE McCarthy, V Makarov, G Kirov, AM Addington, J McClellan, S Yoon, ... Nature genetics 41 (11), 1223-1227, 2009 | 815 | 2009 |
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs B Devlin, JR Kelsoe, P Sklar, MJ Daly, MC O'Donovan, N Craddock, ... Nature genetics 45 (9), 984-994, 2013 | 755 | 2013 |
Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline HA Nasrallah, JM Meyer, DC Goff, JP McEvoy, SM Davis, TS Stroup, ... Schizophrenia research 86 (1-3), 15-22, 2006 | 748 | 2006 |
The National Institute of Mental Health clinical antipsychotic trials of intervention effectiveness (CATIE) project: schizophrenia trial design and protocol development TS Stroup, JP McEvoy, MS Swartz, MJ Byerly, ID Glick, JM Canive, ... Schizophrenia bulletin 29 (1), 15-31, 2003 | 717 | 2003 |
A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls DC Goff, LM Sullivan, JP McEvoy, JM Meyer, HA Nasrallah, GL Daumit, ... Schizophrenia research 80 (1), 45-53, 2005 | 715 | 2005 |
Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases A Gusev, SH Lee, G Trynka, H Finucane, BJ Vilhjálmsson, H Xu, C Zang, ... The American Journal of Human Genetics 95 (5), 535-552, 2014 | 652 | 2014 |
Baseline neurocognitive deficits in the CATIE schizophrenia trial RSE Keefe, RM Bilder, PD Harvey, SM Davis, BW Palmer, JM Gold, ... Neuropsychopharmacology 31 (9), 2033-2046, 2006 | 589 | 2006 |
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic TS Stroup, JA Lieberman, JP McEvoy, MS Swartz, SM Davis, ... American Journal of Psychiatry 163 (4), 611-622, 2006 | 579 | 2006 |